Wingtech says it will appeal against Dutch court order in Nexperia dispute

By Reuters News

- Wingtech Technology 600745.SS will appeal against a Dutch court's interim ruling in a dispute over control of its chipmaking subsidiary Nexperia, according to a filing to the Shanghai Stock Exchange on Sunday.

  • The dispute was triggered when the Dutch state took control of Nexperia in September last year, citing worries about the possible transfer of technology from Dutch chipmaker Nexperia to Chinese parent company Wingtech

  • The Dutch government stepped back from its intervention in November last year, but the dispute has since led to litigation in both the Netherlands and China

  • Last week, the Enterprise Chamber of the Amsterdam district court ordered additional measures to protect Nexperia from interference by Wingtech

  • It ordered Wingtech, founder Zhang Xuezheng, Nexperia China and others in Wingtech's leadership to refrain from interfering with Nexperia's normal business activities

  • Wingtech said in the stock market filing on Sunday that the decision lacked a factual and legal basis and improperly interfered with ongoing judicial proceedings in China

  • Wingtech added that the court had also ordered it to withdraw parts of a lawsuit filed in China this year

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.